Active ingredients
Pharmacological Group
Used in the treatment
- T42 Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs
- P21 Birth asphyxia
- K72 Hepatic failure, not elsewhere classified
- J96 Respiratory failure, not elsewhere classified
- J18 Pneumonia, organism unspecified
- I99 Other and unspecified disorders of circulatory system
- I67.9 Cerebrovascular disease, unspecified
- I51.9 Heart disease, unspecified
- I50.9 Heart failure, unspecified
- H35.3 Degeneration of macula and posterior pole
- H18.4 Corneal degeneration
- H17 Corneal scars and opacities
- H16 Keratitis
- E63 Other nutritional deficiencies
- B19 Unspecified viral hepatitis
- T58 Toxic effect of carbon monoxide
- Z100* CHAPTER XXII Surgical practice
- T59.8 Toxic effect, other specified gases, fumes and vapours
- R06 Abnormalities of breathing
- H30-H36 Diseases of the choroid and retina
- B15-B19 Viral hepatitis
- J96.1 Chronic respiratory failure